⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27735663 | 0.87 | CA2 (0.58) | — | |
| Ethylene SCHEMBL31295702 | 0.82 | CA2 (0.64) | — | |
| SCHEMBL6114 | 0.82 | — | — | |
| SCHEMBL1506860 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL2210811 | 0.79 | — | — | |
| SCHEMBL10670323 | 0.79 | — | — | |
| SCHEMBL8387892 | 0.79 | — | — | |
| SCHEMBL8573707 | 0.79 | — | — | |
| SCHEMBL97792 | 0.79 | — | — | |
| SCHEMBL1506849 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6232324-B1 | AS HYPERTENSIVE AGENTS FOR DIALYSIS INDUCED HYPOTENSION; ADMINISTERING COMPOUNDS SUCH AS 1-(3-(2-PHENYLPYRAZOLO(1,5-A) PYRIDIN-3-YL)ACRYLOYL)-2-(CARBOXY METHYL)PIPERIDINE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-15 | — | — | US | claimed |
| US-20240118270-A1 | METHOD FOR STABILIZING EXTRACELLULAR VESICLES | H.U. GROUP RESEARCH INSTITUTE G.K. (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20230227916-A1 | METHOD FOR RECOVERING EXTRACELLULAR VESICLE | H.U. GROUP RESEARCH INSTITUTE G.K. (JP) | 2023-07-20 | — | — | US | disclosed |
| EP-4137559-A1 | METHOD FOR HARVESTING EXTRACELLULAR VESICLES | H.U. Group Research Institute G.K. (JP) | 2023-02-22 | — | — | EP | disclosed |
| CN-115461445-A | Method for recovering extracellular vesicles | 合同会社予幸集团中央研究所 | 2022-12-09 | — | — | CN | disclosed |
| CN-109963922-B | Aldehyde scavenger and method for removing aldehyde | 东曹株式会社 | 2022-09-23 | — | — | CN | disclosed |
| US-20210396633-A1 | METHOD FOR RECOVERING EXTRACELLULAR VESICLES | H.U. GROUP RESEARCH INSTITUTE G.K. (JP) | 2021-12-23 | — | — | US | disclosed |
| CN-113039422-A | Method for recovering extracellular vesicles | 合同会社予幸集团中央研究所 | 2021-06-25 | — | — | CN | disclosed |
| EP-3730603-A1 | METHOD FOR STABILIZING EXTRACELLULAR VESICLES | H.U. Group Research Institute G.K. (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-20200319175-A1 | METHOD FOR STABILIZING EXTRACELLULAR VESICLES | MIRACA RESEARCH INSTITUTE G.K. (JP) | 2020-10-08 | — | — | US | disclosed |
| EP-0263229-A1 | Phenol derivatives, their preparation and the use thereof | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-04-13 | — | — | EP | disclosed |
| US-4631339-A | 1,3,5-triazepinones | ELI LILLY AND COMPANY (US) | 1986-12-23 | — | — | US | disclosed |
| US-4565655-A | Diazabicyclononene antibacterials | ELI LILLY AND COMPANY (US) | 1986-01-21 | — | — | US | disclosed |
| US-4514564-A | 7β-(2'-(1\",3\",5\"-Triazepin-4\"-one)-2'-(oxime ether)-acetamido)-3-substituted cephalosporins | ELI LILLY AND COMPANY (US) | 1985-04-30 | — | — | US | disclosed |
| US-4436912-A | 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor | ELI LILLY AND COMPANY (US) | 1984-03-13 | — | — | US | disclosed |
| US-4430499-A | 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1984-02-07 | — | — | US | disclosed |
| US-4401668-A | BACTERICIDES | ELI LILLY AND COMPANY (US) | 1983-08-30 | — | — | US | disclosed |
| US-4396619-A | ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1983-08-02 | — | — | US | disclosed |
| US-4388316-A | BACTERICIDES | ELI LILLY AND COMPANY (US) | 1983-06-14 | — | — | US | disclosed |
| US-4382932-A | Isoquinolinium substituted cephalosporins | ELI LILLY AND COMPANY (US) | 1983-05-10 | — | — | US | disclosed |